论文部分内容阅读
1临床资料患者,男,34岁,体质量78 kg,本人及家族无药物过敏史及药品不良反应史,于2013年1月16日因上呼吸道感染后继发咳嗽在我院门诊就诊,自诉于1月5日始有感冒症状,表现为鼻塞、流涕,自服复方盐酸伪麻黄碱缓释胶囊(新康泰克,规格:90 mg盐酸伪麻黄碱/片)1片,bid,3 d后症状缓解,即停药;9日开始出现咳嗽症状,无其他不适,因咳嗽症状加重前来就诊。诊断为支气管炎。给予莫西沙星(拜复乐,拜耳医药保健有限公司,批号:BJO7430,规格:400 mg/片)400 mg,po,qd。此外给予祛痰、镇咳药,因患者依从性不佳,仅当天服用莫西沙星400 mg。1月17日,患者发现对各
1 clinical data of patients, male, 34 years old, body mass 78 kg, I and the family history of drug allergy and adverse drug reactions, on January 16, 2013 due to upper respiratory tract infection after cough in our hospital clinic, January 5 began a cold symptoms, manifested as stuffy nose, runny nose, self-service compound pseudoephedrine hydrochloride ephedrine capsules (new Contac specifications: 90 mg pseudoephedrine hydrochloride tablets), bid, 3 d after the symptom? Withdrawal; 9 began to appear cough symptoms, no other discomfort, due to increased cough symptoms come to see a doctor. Diagnosis of bronchitis. Moxifloxacin (Bai Fu Le, Bayer HealthCare, batch number: BJO7430, specifications: 400 mg / tablet) 400 mg, po, qd. In addition to expectorant, antitussive, due to poor patient compliance, only the day taking moxifloxacin 400 mg. January 17, patients found each